NCT04447040 - Acetaminophen/Naproxen Sodium Dose Ranging Study | Biotech Hunter

Enrollment

304

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

April 9, 2021

Study Completion Date

May 3, 2021

Conditions

Pain

Interventions

DRUG

Acetaminophen/naproxen sodium Dose A

Acetaminophen/naproxen sodium Dose A administered as a single two-tablet dose.

DRUG

Acetaminophen/naproxen sodium Dose B

Acetaminophen/naproxen sodium Dose B administered as a single two-tablet dose.

DRUG

Acetaminophen/naproxen sodium Dose C

Acetaminophen/naproxen sodium Dose C administered as a single two-tablet dose.

DRUG

Acetaminophen/naproxen sodium Dose D

Acetaminophen/naproxen sodium Dose D administered as a single two-tablet dose.

DRUG

Acetaminophen/naproxen sodium Dose E

Acetaminophen/naproxen sodium Dose E administered as a single two-tablet dose.

DRUG

Placebo

Placebo tablets administered as a single two-tablet dose.

Trial Locations (1)

JBR Clinical Research, Salt Lake City

All Listed Sponsors

lead

Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division

INDUSTRY